Perspectives

Horizon scan: multiple myeloma treatment landscape 3:20
Horizon scan: multiple myeloma treatment landscape
Claudio Cerchione • 3 Mar 2021
Supporting future generations of female healthcare professionals 1:18
Supporting future generations of female healthcare professionals
Elena Zamagni • 2 Mar 2021
Monoclonal antibodies for smoldering or newly diagnosed myeloma 1:29
Monoclonal antibodies for smoldering or newly diagnosed myeloma
Elena Zamagni • 2 Mar 2021
The importance of regular sFLC assessment in myeloma 3:05
The importance of regular sFLC assessment in myeloma
Uros Markovic • 26 Feb 2021
Monoclonal antibody therapies for multiple myeloma 2:08
Monoclonal antibody therapies for multiple myeloma
Mattia D'Agostino • 26 Feb 2021
Highlights from TCT 2021 3:55
Highlights from TCT 2021
Pavan Reddy • 24 Feb 2021
Future directions of immune cell therapy in lymphoma 1:29
Future directions of immune cell therapy in lymphoma
Yago Nieto • 15 Feb 2021
TCT 2021: oxygen sensing, pediatric CAR-T & the microbiome 4:23
TCT 2021: oxygen sensing, pediatric CAR-T & the microbiome
Pavan Reddy • 24 Feb 2021
ASTCT response to the COVID-19 pandemic 3:16
ASTCT response to the COVID-19 pandemic
Pavan Reddy • 24 Feb 2021
Narsoplimab for adult TA-TMA 0:46
Narsoplimab for adult TA-TMA
Sergio A. Giralt • 22 Feb 2021
Focus of the ASTCT in 2021 and beyond 2:25
Focus of the ASTCT in 2021 and beyond
Pavan Reddy • 24 Feb 2021
The CIBMTR COVID-19 experience 3:10
The CIBMTR COVID-19 experience
Marcie Riches • 15 Feb 2021
Highlights from TCT 2021: microbiome & impact of COVID-19 2:23
Highlights from TCT 2021: microbiome & impact of COVID-19
Marcie Riches • 15 Feb 2021
Transplantation in patients with myelofibrosis 4:44
Transplantation in patients with myelofibrosis
Ruben Mesa • 17 Feb 2021
ESH CML/MPNs 2021: what to expect? 2:04
ESH CML/MPNs 2021: what to expect?
Ruben Mesa • 17 Feb 2021
The progression of research into CAR T-cell therapy 0:52
The progression of research into CAR T-cell therapy
Hisse M. van Santen • 8 Feb 2021
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals